Mount Sinai Awarded Five-Year, $20.7 Million Vaccine Development Agreement to Advance Next-Generation Technologies Against Respiratory Threats
October 13, 2026
October 13, 2026
NEW YORK, Oct. 13 [Category: BizHospital] -- Mount Sinai Health System posted the following news release:
* * *
Mount Sinai Awarded Five-Year, $20.7 Million Vaccine Development Agreement to Advance Next-Generation Technologies Against Respiratory Threats
*
Researchers at the Icahn School of Medicine at Mount Sinai have been awarded a five-year project agreement to develop Vaccine Immunoengineering for Targeted Antigen Presentation and Layered C . . .
* * *
Mount Sinai Awarded Five-Year, $20.7 Million Vaccine Development Agreement to Advance Next-Generation Technologies Against Respiratory Threats
*
Researchers at the Icahn School of Medicine at Mount Sinai have been awarded a five-year project agreement to develop Vaccine Immunoengineering for Targeted Antigen Presentation and Layered C . . .